
Sazovia 0.2mg Tablet
Marketer
Hauz Pharma Pvt Ltd
Salt Composition
Voglibose (0.2mg)
Overview Sazovia 0.2mg Tablet
Diabeva 0.2mg tablets are prescribed for managing type 2 diabetes. This medication aids in post-meal blood glucose regulation, employed when dietary changes and other similar medications prove insufficient to control elevated blood sugar. Diabeva 0.2mg should be ingested immediately prior to meals. Dosage and frequency are determined by your physician to optimize blood sugar control. Discontinuing this medication abruptly without consulting your doctor is strongly discouraged; doing so risks dangerously elevated blood sugar and potential serious complications such as renal impairment and vision loss. This medication forms one component of a comprehensive treatment strategy encompassing a balanced diet, regular physical activity, and weight management as directed by your healthcare provider. Regular blood glucose monitoring is essential while using Diabeva. Commonly reported side effects include bloating, abdominal discomfort, decreased appetite, constipation, and diarrhea. Report any persistent or bothersome side effects to your physician. While Diabeva itself does not typically induce hypoglycemia, concomitant use with other diabetes medications (particularly insulin or sulfonylureas) elevates this risk. Glucose (dextrose) is the appropriate countermeasure for hypoglycemic episodes; table sugar is ineffective. Inform your doctor of any kidney or liver conditions before commencing treatment. This medication is contraindicated for individuals with bowel inflammation or ulceration (e.g., ulcerative colitis, Crohn's disease). Pregnant or nursing women should seek medical advice before use. Full disclosure of all other medications is necessary to ensure patient safety. Limit alcohol consumption while taking Diabeva to minimize the risk of hypoglycemia.
Uses of Sazovia 0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Sazovia 0.2mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Administer the Sazovia 0.2mg Tablet on an empty stomach.
Common Side effects of Sazovia 0.2mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Sazovia 0.2mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Sazovia 0.2mg Tablet on an empty stomach.
How Sazovia 0.2mg Tablet works:
Sazovia 0.2mg tablets are used to manage diabetes. By blocking enzymes in the intestines that digest complex carbohydrates, they reduce the rapid post-meal surge in blood glucose.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Sazovia 0.2mg Tablet is inadvisable.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Sazovia 0.2mg tablets is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; however, clinical data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Sazovia 0.2mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Sazovia 0.2mg tablets.
KidneyCAUTION
Patients with severe kidney impairment should use Sazovia 0.2mg tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Sazovia 0.2mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Sazovia 0.2mg Tablet :
Omit any missed Sazovia 0.2mg Tablet dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Sazovia 0.2mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Alpha-glucosidase inhibitors |
